1-7 of 7
Barb Bryant
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Expression of Cancer Testis Antigens as Potential Targets for Immunotherapy Is Retained Following Treatment in Multiple Myeloma.

Mark van Duin, Surinder S. Sahota, Yvonne de Knegt, Annemiek Broyl, Debora Joseph-Pietras, George Mulligan, Barb Bryant, Pieter Sonneveld
Journal: Blood
Blood (2008) 112 (11): 1722.
https://doi.org/10.1182/blood.V112.11.1722.1722
Published: 2008
Journal Articles

High-risk myeloma: a gene expression–based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone

Fenghuang Zhan, Bart Barlogie, George Mulligan, John D. Shaughnessy, Jr, Barb Bryant
Journal: Blood
Blood (2008) 111 (2): 968–969.
https://doi.org/10.1182/blood-2007-10-119321
Published: 2008
Journal Articles

Immunohistochemical Analyses for Potential Biomarkers of Bortezomib Activity in Mantle Cell Lymphoma from the PINNACLE Phase 2 Trial.

Andre Goy, Steven H. Bernstein, Alice McDonald, Michael D. Pickard, Mark D. Fleming, Barb Bryant, William Trepicchio, Richard I. Fisher, Anthony Boral, George Mulligan
Journal: Blood
Blood (2007) 110 (11): 2573.
https://doi.org/10.1182/blood.V110.11.2573.2573
Published: 2007
Journal Articles

Pharmacogenomics Study of Biological Pathways Related to Bortezomib Activity in Myeloma.

George Mulligan, Barb Bryant, Steven Roels, Andrew Bolt, Yan Meng, Erik Koenig, Anthony Boral, Dixie-Lee Esseltine, Kenneth A. Anderson, Peter Leif Bergsagel, Pieter Sonneveld, Annemiek Broyl, Constantine Mitsiades, Wee-Joo Chng, Paul G. Richardson, William Trepicchio
Journal: Blood
Blood (2007) 110 (11): 392.
https://doi.org/10.1182/blood.V110.11.392.392
Published: 2007
Journal Articles

High-Resolution Assessment of Gains and Losses of Chromosomes in Patients with Multiple Myeloma Treated with Bortezomib.

Hadi Danaee, Barb Bryant, Steve Roels, Dave Lichter, Eric Koening, William L. Trepicchio, Anthony Boral, Paul Richardson, Yan Meng, Peter Leif Bergsagel, Pieter Sonneveld, Annemiek Broyl, Constantine Mitsiades, Wee-Joo Chng, Kenneth Anderson, George Mulligan
Journal: Blood
Blood (2007) 110 (11): 4763.
https://doi.org/10.1182/blood.V110.11.4763.4763
Published: 2007
Journal Articles

A Gene Expression-Based Risk Stratification Model Developed in Newly Diagnosed Multiple Myeloma Treated with High Dose Therapy Is Predictive of Outcome in Relapsed Disease Treated with Single Agent Bortezomib.

Fenghaung Zhan, Barb Bryant, Bart Barlogie, George Mulligan, John D. Shaughnessy, Jr.
Journal: Blood
Blood (2007) 110 (11): 656.
https://doi.org/10.1182/blood.V110.11.656.656
Published: 2007
Journal Articles

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

Clinical Trials & Observations
George Mulligan, Constantine Mitsiades, Barb Bryant, Fenghuang Zhan, Wee J. Chng, Steven Roels, Erik Koenig, Andrew Fergus, Yongsheng Huang, Paul Richardson, William L. Trepicchio, Annemiek Broyl, Pieter Sonneveld, John D. Shaughnessy, Jr, P. Leif Bergsagel, David Schenkein, Dixie-Lee Esseltine, Anthony Boral, Kenneth C. Anderson
Journal: Blood
Blood (2006) 109 (8): 3177–3188.
https://doi.org/10.1182/blood-2006-09-044974
Published: 2006
Includes: Supplemental data